TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23897229

Group type: EXPERIMENTAL
Intervention: Mupirocin ointment
Number of subjects: 203

Group type: COMPARATOR
Intervention: Gentamicin cream
Number of subjects: 203
Study: 21672346

Group type: EXPERIMENTAL
Intervention: Double-contrast CT arthrography
Number of subjects: 125

Group type: COMPARATOR
Intervention: Conservative management (with physical rehabilitation) or standard surgery
Number of subjects: 125
Study: 19835717

Group type: EXPERIMENTAL
Intervention: E2V/DNG
Number of subjects: 798

Group type: COMPARATOR
Intervention: EE/LNG
Number of subjects: 798
Study: 16982546

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) with a central dose of 15 Gy x 3 within 5-8 days
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 64
Study: 15249794

Group type: COMPARATOR
Intervention: Established group (weight loss, increased physical activity, reduced sodium and alcohol intake)
Number of subjects: 810

Group type: COMPARATOR
Intervention: Established plus DASH diet group (established interventions plus DASH dietary pattern)
Number of subjects: 810

Group type: COMPARATOR
Intervention: Advice-only group
Number of subjects: 810
Study: 10884441

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 9065178

Group type: EXPERIMENTAL
Intervention: Posterior pubourethral ligament plication
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Pereyra suspension
Number of subjects: 109
Study: 8376720

Group type: EXPERIMENTAL
Intervention: Ocutech VES (experimental device)
Number of subjects: 56

Group type: COMPARATOR
Intervention: DFV Expanded Field or Walter's Keplarian Close‐focus Telescope (control)
Number of subjects: 56
Study: 3533421

Group type: EXPERIMENTAL
Intervention: Luteinizing hormone releasing hormone (LHRH) injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Testosterone injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hormonal fluctuations of the menstrual cycle in women
Number of subjects: 0
Study: 31650314

Group type: EXPERIMENTAL
Intervention: Warm local anesthetic (37 °C)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Room temperature local anesthetic (21 °C)
Number of subjects: 100
Study: 31140759

Group type: EXPERIMENTAL
Intervention: Weight stigma experienced by parents
Number of subjects: 453
Study: 28645985

Group type: EXPERIMENTAL
Intervention: Individualised web-delivered cognitive behavioural intervention (CancerCope)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Static patient education website
Number of subjects: 163
Study: 25487220

Group type: EXPERIMENTAL
Intervention: Program SI! intervention for cardiovascular health promotion
Number of subjects: 2011

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI) classification
Number of subjects: 2011

Group type: EXPERIMENTAL
Intervention: Sex- and age-specific criteria for obesity
Number of subjects: 2011
Study: 23329167

Group type: EXPERIMENTAL
Intervention: Computer Agent
Number of subjects: 15
Study: 21219106

Group type: EXPERIMENTAL
Intervention: 10 ml of 2% lidocaine
Number of subjects: 104

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 104
Study: 18845585

Group type: EXPERIMENTAL
Intervention: Web-based program for working parents
Number of subjects: 99

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 99
Study: 16377978

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (4 x 5 g creatine monohydrate per day for 5 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 15253143

Group type: EXPERIMENTAL
Intervention: Monophasic waveform (group I)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Rectilinear biphasic waveform (group II)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Biphasic truncated waveform (group III)
Number of subjects: 64
Study: 12228196

Group type: EXPERIMENTAL
Intervention: Low-dose involved-field radiotherapy (LD-IFRT)
Number of subjects: 501

Group type: COMPARATOR
Intervention: No further therapy
Number of subjects: 501
Study: 9589294

Group type: EXPERIMENTAL
Intervention: 99mTc‐HMPAO‐white blood cell scans in patients with active CD
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: 99mTc‐HMPAO‐white blood cell scans in patients with active UC
Number of subjects: 215

Group type: COMPARATOR
Intervention: 99mTc‐HMPAO‐white blood cell scans in controls
Number of subjects: 215
Study: 7979858

Group type: EXPERIMENTAL
Intervention: Antibody against oxidized low-density lipoprotein
Number of subjects: 135

Group type: COMPARATOR
Intervention: Lowest tertile of antibody level
Number of subjects: 135
Study: 2742097

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 80
Study: 29952687

Group type: EXPERIMENTAL
Intervention: e‐Exercise (12-week blended intervention with face-to-face physiotherapy sessions and a web-based application)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: e‐Exercise
Number of subjects: 123
Study: 30622099

Group type: EXPERIMENTAL
Intervention: Cigarette users
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Waterpipe users
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Nass users
Number of subjects: 165

Group type: COMPARATOR
Intervention: Never tobacco users
Number of subjects: 165
Study: 28071865

Group type: EXPERIMENTAL
Intervention: Post-implementation of sepsis guidelines
Number of subjects: 165
Study: 25896747

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) once a week for 12 weeks
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Baseline startle reflex to alcohol cues
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Baseline startle reflex elicited by alcohol-associated stimuli
Number of subjects: 98
Study: 23912022

Group type: EXPERIMENTAL
Intervention: Developmental maternally administered intervention (Hospital to Home Transition‐Optimizing Premature Infant's Environment)
Number of subjects: 142
Study: 21684353

Group type: EXPERIMENTAL
Intervention: High-dose rosuvastatin (20mg orally for 14 days, 7 days before and after surgery) plus low-molecular-weight heparin (LMWH) (40 mg enoxaparin subcutaneously starting 12h prior to surgery and continuing for 7 days)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional LMWH therapy (40 mg enoxaparin subcutaneously starting 12h prior to surgery and continuing for 7 days)
Number of subjects: 180
Study: 19325478

Group type: EXPERIMENTAL
Intervention: High-frequency percussive ventilation (HFPV)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 53
Study: 16766543

Group type: EXPERIMENTAL
Intervention: Candesartan 4-8 mg/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nothing (control)
Number of subjects: 80
Study: 15004678

Group type: EXPERIMENTAL
Intervention: Störkel's prognostic score
Number of subjects: 129

Group type: COMPARATOR
Intervention: TNM classification (including subdivision of stage pT1 into pT1a and pT1b)
Number of subjects: 129
Study: 10791451

Group type: EXPERIMENTAL
Intervention: Single osmotic laxative
Number of subjects: 206

Group type: COMPARATOR
Intervention: Osmotic agent along with a rectal stimulant and weekly enemas
Number of subjects: 206
Study: 9289439

Group type: EXPERIMENTAL
Intervention: Double antibodies radioimmunoassay of human cortisol binding globulin serum level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard curve using specific Bx/Box100%
Number of subjects: 0
Study: 1847291

Group type: EXPERIMENTAL
Intervention: Buffered bupivicaine (0.5% with sodium bicarbonate, pH adjusted to 7.0)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Unbuffered bupivicaine (control)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Comparison of buffered vs unbuffered bupivicaine
Number of subjects: 62
Study: 6339152

Group type: EXPERIMENTAL
Intervention: Insulin infusion with glucose
Number of subjects: 17
Study: 31761417

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 64

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 64
Study: 29846693

Group type: EXPERIMENTAL
Intervention: Preoperative multiparametric magnetic resonance imaging (MRI) features
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: SHH-specific nomogram
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Group 4 nomogram
Number of subjects: 111
Study: 28697202

Group type: EXPERIMENTAL
Intervention: Neutral zone (NZ) mandibular denture
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional (CV) mandibular denture
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: No preference
Number of subjects: 37
Study: 25738669

Group type: EXPERIMENTAL
Intervention: 6 months of valganciclovir therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: 6 weeks of valganciclovir therapy
Number of subjects: 96
Study: 23770519

Group type: EXPERIMENTAL
Intervention: Country-level mean length of stay
Number of subjects: 6848

Group type: EXPERIMENTAL
Intervention: Length of stay across US study sites
Number of subjects: 6848
Study: 21566548

Group type: EXPERIMENTAL
Intervention: Topical containing TLR2‐Regul™
Number of subjects: 115

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 115
Study: 19594648

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study: 16499254

Group type: EXPERIMENTAL
Intervention: New patients
Number of subjects: 1834

Group type: EXPERIMENTAL
Intervention: Previously treated patients
Number of subjects: 1834
Study: 15562053

Group type: EXPERIMENTAL
Intervention: IV tranexamic acid (TA) 15 mg/kg bolus over 30 min followed by IV infusion of 10 mg . kg(‐1) . h(‐1) for 12 h
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: IV tranexamic acid (TA) similar to TA-long but infusion discontinued 2 h after deflation, followed by oral TA 1 g after 6 and 12 h
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid (TA) 1 g administered 60 min before surgery, followed by 1 g every 6 h for 18 h
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no tranexamic acid administered)
Number of subjects: 80
Study: 11054523

Group type: EXPERIMENTAL
Intervention: Androgen deprivation (AD) started immediately after diagnosis (IAD)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Deferred treatment policy (DAD)
Number of subjects: 26
Study: 9232145

Group type: EXPERIMENTAL
Intervention: Electronic anesthesia record keeping (EARK)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional manual recording (MAN)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EARK
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: TEE use
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Before intubation
Number of subjects: 20
Study: 1283143

Group type: EXPERIMENTAL
Intervention: Laser therapy with additional external beam radiotherapy (30 Gy in 10-20 fractions)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Laser therapy with additional external beam radiotherapy (40 Gy in 10-20 fractions)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combined treatment (Laser therapy + external beam radiotherapy)
Number of subjects: 22
Study: 6728874

Group type: EXPERIMENTAL
Intervention: Ethanol 0.7 g/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ethanol 0.5 g/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Caffeine 5 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ethanol 0.5 g/kg and Caffeine 5 mg/kg combined
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcohol placebo and caffeine placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcohol placebo and caffeine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcohol and caffeine placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol and caffeine
Number of subjects: 0
Study: 3543278

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 41
Study: 29357332

Group type: COMPARATOR
Intervention: Physical exercise protocol (mild exercise)
Number of subjects: 20
Study: 26708361

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Squatting Control
Number of subjects: 28
Study: 25331894

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes group
Number of subjects: 140

Group type: COMPARATOR
Intervention: Nondiabetic control group
Number of subjects: 140
Study: 23292040

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once daily with itopride 50 mg three times daily
Number of subjects: 64

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg once daily
Number of subjects: 64
Study: 20579392

Group type: EXPERIMENTAL
Intervention: Household-level incentives for ITN use (bonus for ITN use after visual confirmation)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no incentives)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Household-level incentives for ITN use
Number of subjects: 21
Study: 18065277

Group type: EXPERIMENTAL
Intervention: Wide-angle colonoscope (WA)
Number of subjects: 710

Group type: COMPARATOR
Intervention: Standard colonoscope (ST)
Number of subjects: 710
Study: 16895634

Group type: EXPERIMENTAL
Intervention: Letrozole (5 mg/day from day 3 to day 7 of the IUI cycle)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Human menopausal gonadotrophin (HMG) (75 IU for women under 30 years old and 150 IU for women over 30 years old)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Human menopausal gonadotrophin (HMG)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 80
Study: 15022582

Group type: EXPERIMENTAL
Intervention: Topical retinoid therapy (tretinoin) applied via iontophoresis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical retinoid therapy (tretinoin)
Number of subjects: 0
Study: 10777006

Group type: EXPERIMENTAL
Intervention: Mammographic density in more than 75% of breast area
Number of subjects: 888

Group type: COMPARATOR
Intervention: Comparison group (women with no density)
Number of subjects: 888
Study: 8887606

Group type: EXPERIMENTAL
Intervention: Impedance-triggered system
Number of subjects: 10

Group type: COMPARATOR
Intervention: Flow/volume-triggered system
Number of subjects: 10
Study: 1984215

Group type: EXPERIMENTAL
Intervention: Intracervical prostaglandin (PG) E2 gel
Number of subjects: 168

Group type: COMPARATOR
Intervention: Double balloon device with PGE2 gel
Number of subjects: 168

Group type: COMPARATOR
Intervention: Double balloon device with placebo gel
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Double balloon device alone (without PGE2)
Number of subjects: 168
Study: 6337609

Group type: EXPERIMENTAL
Intervention: mianserin 60 mg nocte
Number of subjects: 80

Group type: COMPARATOR
Intervention: nomifensine 150 mg daily
Number of subjects: 80
Study: 30739128

Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg (one capsule before surgery and one capsule once per night up till postoperative day 2)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo (one capsule before surgery and one capsule once per night up till postoperative day 2)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 30172037

Group type: EXPERIMENTAL
Intervention: Home-based peer delivered self-management intervention (5 home visits and 5 phone calls with a peer health coach)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 400
Study: 27142674

Group type: EXPERIMENTAL
Intervention: Passive Scattering Proton Therapy (PSPT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Intensity Modulation Radiation Therapy (IMRT)
Number of subjects: 52
Study: 25372582

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/day
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg/day
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/day and 40 mg/day combined
Number of subjects: 21
Study: 23135096

Group type: EXPERIMENTAL
Intervention: TCA 80%
Number of subjects: 55

Group type: COMPARATOR
Intervention: TCA 35%
Number of subjects: 55
Study: 20473044

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg/d
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Venlafaxine 37.5 mg/d
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 18028529

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 16480165

Group type: EXPERIMENTAL
Intervention: Standard five-needle National Acupuncture Detoxification Association (NADA) protocol
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Reduced, escalating dose (one to three needle) protocol
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acupuncture with spirituality-focused group therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acupuncture without spirituality-focused group therapy
Number of subjects: 40
Study: 11570836

Group type: EXPERIMENTAL
Intervention: TTM intervention (three whole class lessons and three sessions with an interactive computer program)
Number of subjects: 4227

Group type: COMPARATOR
Intervention: Control (no special intervention)
Number of subjects: 4227

Group type: EXPERIMENTAL
Intervention: TTM intervention
Number of subjects: 4227

Group type: COMPARATOR
Intervention: Control
Number of subjects: 4227
Study: 9459113

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 190 mg/kg/day
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 8147930

Group type: EXPERIMENTAL
Intervention: Diacerhein and Tenoxicam
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Tenoxicam
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Diacerhein
Number of subjects: 288
Study: 3202925

Group type: EXPERIMENTAL
Intervention: Alcohol ingestion (mean serum ethanol 35 mmol/l)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Alcohol ingestion (serum ethanol 21 mmol/l)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Isovolumic, isocaloric drink
Number of subjects: 7
Study: 31196759

Group type: EXPERIMENTAL
Intervention: Computed tomography-guided platinum microcoil lung surgery
Number of subjects: 92
Study: 27993588

Group type: EXPERIMENTAL
Intervention: Verum-focused extracorporeal shock wave therapy (energy flux density, .06‐.09mJ/mm2; pulse ratio per point, 200)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham-focused extracorporeal shock wave therapy (no energy)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: All groups (including verum, sham, and no intervention)
Number of subjects: 46
Study: 25951632

Group type: EXPERIMENTAL
Intervention: Qingying Huoxue Decoction (QHD) combined with ursodeoxycholic acid (UDCA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: ursodeoxycholic acid (UDCA) alone
Number of subjects: 78

Group type: COMPARATOR
Intervention: Both groups (treatment and control)
Number of subjects: 78
Study: 24010736

Group type: EXPERIMENTAL
Intervention: GSK2190915 300 mg QD (add-on to FP)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: GSK2190915 300 mg QD (add-on to FP/salmeterol)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: GSK2190915 100 mg QD (add-on to FP)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg QD (add-on to FP)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 µg BID (add-on to FP)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Placebo (add-on to FP)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg QD (add-on to FP/salmeterol)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Placebo (add-on to FP/salmeterol)
Number of subjects: 307
Study: 21896927

Group type: EXPERIMENTAL
Intervention: DiaPep277
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study: 19517341

Group type: EXPERIMENTAL
Intervention: Power Port (Bard)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: T-Port-Contrast (PFM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: X-Port (BARD)
Number of subjects: 40
Study: 17545346

Group type: EXPERIMENTAL
Intervention: Quality circles intervention (self-led meeting with material introduced by a research team member)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard dissemination of the guideline by mail (control group)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Quality circles intervention
Number of subjects: 75
Study: 15577058

Group type: EXPERIMENTAL
Intervention: Parathyroid hormone (PTH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PTH and anti-resorptive agents (concurrent or sequential therapies)
Number of subjects: 0
Study: 11579859

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 570

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 570
Study: 9560175

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy plus graded exposure
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Relaxation Training plus graded exposure
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: therapist-assisted graded exposure alone
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Self-directed exposure practice
Number of subjects: 74
Study: 7889814

Group type: EXPERIMENTAL
Intervention: 40% nitrous oxide in oxygen
Number of subjects: 0

Group type: COMPARATOR
Intervention: 100% oxygen (placebo)
Number of subjects: 0
Study: 3279757

Group type: EXPERIMENTAL
Intervention: 1 g amoxycillin suspension twice a day for 8 days
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Amoxycillin single blind for 14 days (in second study phase)
Number of subjects: 45
Study: 30195124

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Brisk Walking
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control
Number of subjects: 246
Study: 27058680

Group type: EXPERIMENTAL
Intervention: Training with human pain assessment (T+)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Training with automated pain assessment (T)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No training with automated pain assessment (C)
Number of subjects: 0
Study: 24828327

Group type: EXPERIMENTAL
Intervention: 0.9% saline
Number of subjects: 42

Group type: COMPARATOR
Intervention: Colloid solution (gelatin, hydroxyethyl starch 200/0.5 or albumin)
Number of subjects: 42